Binding of calcium ions and their effect on clotting of fibrinogen Milano III, a variant with truncated Aα-chains

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 3, 1996, Pages 331-335

  Furlan, M ^a   Steinmann, C ^a   Jungo, M ^a   Lammle B ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Alpha chain; Calcium ions; Dysfibrinogenaemia; Fibrinogen variant

Indexed keywords

CALCIUM; FIBRINOGEN;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DYSFIBRINOGENEMIA; GENE MUTATION; HUMAN; PRIORITY JOURNAL;

EID: 0029950790     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199604000-00007     Document Type: Article

References (29)

1. Boyer MH, Shainoff JR, Ratnoff OD. Acceleration of fibrin polymerization by calcium ions. Blood 1972; 39: 382-387.
2. Endres GF, Scheraga HA. Equilibria in the fibrinogen-fibrin conversion. IX. Effects of calcium ions on the reversible polymerization of fibrin monomer. Arch Biochem Biophys 1972; 153: 266-278.
3. Brass EP, Forman WB, Edwards RV, et al. Fibrin formation: effect of calcium ions. Blood 1978; 52: 654-658.
4. Kanaide H, Uranishi T, Nakamura M. Effects of divalent cations on the conversion of fibrinogen to fibrin and fibrin polymerization. Am J Hematol 1982; 13: 229-237.
5. Okada M, Blombäck B. Calcium and fibrin gel structure. Thromb Res 1983; 29: 269-280.
6. Marguerie G, Benabid Y, Suscillon M. The binding of calcium to fibrinogen: influence on the clotting process. Biochim Biophys Acta 1979; 579: 134-141.
7. Lindsey GG, Brown G, Purves LR. Calcium binding to human fibrinogen - localization of two calcium specific sites. Thromb Res 1978; 13: 345-350.
8. Nieuwenhuizen W, Vermond A, Nooijen WJ, et al. Calcium-binding properties of human fibrin(ogen) and degradation products. FEBS Lett 1979; 98: 257-259.
9. Nieuwenhuizen W, van Ruijven-Vermeer IAM, Nooijen WJ, et al. Recalculation of calcium-binding properties of human and rat fibrin(ogen) and their degradation products. Thromb Res 1981; 22: 653-657.
10. Dang CV, Ebert RF, Bell WR. Localization of a fibrinogen calcium binding site between γ-subunit positions 311 and 336 by terbium fluorescence. J Biol Chem 1985; 260: 9713-9719.
11. Marguerie G, Ardaillou N. Potential role of the Aα chain in the binding of calcium to human fibrinogen. Biochim Biophys Acta 1982; 701: 410-412.
12. Nieuwenhuizen W, Gravesen M. Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen, produced by plasmin (fragments X). Biochim Biophys Acta 1981; 668: 81-88.
13. Nieuwenhuizen W, Voskuilen M, Hermans J. Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen (plasmin fragments Y). Biochim Biophys Acta 1982; 708: 313-316.
14. Nieuwenhuizen W, Vermond A, Hermans J. Evidence for the localization of a calcium-binding site in the amino-terminal disulphide knot of fibrin(ogen). Thromb Res 1983; 31: 81-86.
15. Marguerie G, Chagniel G, Suscillon M. The binding of calcium to bovine fibrinogen. Biochim Biophys Acta 1977; 490: 94-103.
16. Okude M, Yamanaka A, Morimoto Y, et al. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot. Biol Pharm Bull 1993; 16: 448-452.
17. Langer BG, Weisel JW, Dinauer PA, et al. Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers. J Biol Chem 1988; 263: 15056-15063.
18. Dang CV, Shin CK, Bell WR, et al. Fibrinogen sialic acid residues are low affinity calcium-binding sites that influence fibrin assembly. J Biol Chem 1989; 264: 15104-15108.
19. Ebert RF. Dysfibrinogenemia: an update and review of the literature. Thromb Haemost 1993; 69: 1296 (abstract).
20. Yoshida N, Hirata H, Asakura S, et al. Calcium binding to abnormal fibrinogens with a single amino acid replacement in the NH2-terminal region of fibrin α-or β-chain. Thromb Res 1992; 67: 613-618.
21. Maekawa H, Yamazumi K, Muramatsu S, et al. An Aα Ser-434 to N-glycosylated Asn substitution in a dysfibrinogen, fibrinogen Caracas II, characterized by impaired fibrin gel formation. J Biol Chem 1991; 266: 11575-11581.
22. Maekawa H, Yamazumi K, Muramatsu S, et al. Fibrinogen Lima: a homozygous dysfibrinogen with an Aα-arginine-141 to serine substitution associated with extra N-glycosylation at Aα-asparagine-139. Impaired fibrin gel formation but normal fibrin-facilitated plasminogen activation catalyzed by tissue-type plasminogen activator. J Clin Invest 1992; 90: 67-76.
23. Koopman J, Haverkate F, Grimbergen J, et al. Molecular basis for fibrinogen Dusart (Aα 554 Arg→Cys) and its association with abnormal fibrin polymerization and thrombophilia. J Clin Invest 1993; 91: 1637-1643.
24. Koopman J, Haverkate F, Grimbergen J, et al. Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids Aα 461-610 (Lys 461 AAA→Stop TAA). Blood 1992; 80: 1972-1979.
25. Furlan M, Steinmann C, Jungo M, et al. A frameshift mutation in exon V of the Aα-chain gene leading to truncated Aα-chains in the homozygous dysfibrinogen Milano III. J Biol Chem 1994; 269: 33129-33134.
26. Furlan M, Rupp C, Beck EA, et al. Effect of calcium and synthetic peptides on fibrin polymerization. Thromb Haemost 1982; 47: 118-121.
27. Scatchard G. The attractions of proteins for small molecules and ions. Ann NY Acad Sci 1949; 51: 660-672.
28. Weisel JW, Papsun DM. Involvement of the COOH-terminal portion of the alpha-chain of fibrin in the branching of fibers to form a clot. Thromb Res 1987; 47: 155-163.
29. Holm B, Brosstad F, Kierulf P, et al. Polymerization properties of two normally circulating fibrinogens, HMW and LMW. Evidence that the COOH-terminal end of the α-chain is of importance for fibrin polymerization. Thromb Res 1985; 39: 595-606.